Navid Sobhani

Scientist, Ph.D.


Curriculum vitae


[email protected]


Department of Cancer Biology

UT MD Anderson Cancer Center



Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma


Journal article


Navid Sobhani, Silvia P Corona, Fabrizio Zanconati, Daniele Generali
Genes Cancer, vol. 8(3-4), 2017, pp. 495-496


Cite

Cite

APA   Click to copy
Sobhani, N., Corona, S. P., Zanconati, F., & Generali, D. (2017). Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma. Genes Cancer, 8(3-4), 495–496. https://doi.org/10.18632/genesandcancer.138


Chicago/Turabian   Click to copy
Sobhani, Navid, Silvia P Corona, Fabrizio Zanconati, and Daniele Generali. “Cyclin Dependent Kinase 4 and 6 Inhibitors as Novel Therapeutic Agents for Targeted Treatment of Malignant Mesothelioma.” Genes Cancer 8, no. 3-4 (2017): 495–496.


MLA   Click to copy
Sobhani, Navid, et al. “Cyclin Dependent Kinase 4 and 6 Inhibitors as Novel Therapeutic Agents for Targeted Treatment of Malignant Mesothelioma.” Genes Cancer, vol. 8, no. 3-4, 2017, pp. 495–96, doi:10.18632/genesandcancer.138.


BibTeX   Click to copy

@article{navid2017a,
  title = {Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma},
  year = {2017},
  issue = {3-4},
  journal = {Genes Cancer},
  pages = {495-496},
  volume = {8},
  doi = {10.18632/genesandcancer.138},
  author = {Sobhani, Navid and Corona, Silvia P and Zanconati, Fabrizio and Generali, Daniele}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in